1. India Stocks

  2. •

    Producer manufacturing

  3. •

    Miscellaneous manufacturing
CCME Global Ltd

CCME Global Ltd

BBSE:CCME
31.81
INR
-1.67
(-4.99%)
-0.29EPS
5.50BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1.28
1.09
- -
0.07
0.25
0.04
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-1.1
-0.62
0.44
- -
-0.17
-0.04
-0.08
-0.09
-0.09
-0.11
-2.92
2.7
-0.55
-0.29
Free Cash Flow per Basic Share
0.02
-6.83
-3.37
-0.25
1.46
-3.61
0.01
-0.09
-0.09
-0.07
- -
- -
3.93
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.77
4.81
6.56
6.65
7.27
7.15
7.07
6.98
6.89
6.79
3.87
6.56
8.85
- -
Tangible Book Value per Share
-0.77
4.81
6.56
6.65
7.27
7.15
7.07
6.98
6.89
6.79
3.87
6.56
8.85
- -
Basic Weighted Avg Shares
3
7
8
10
11
13
13
13
13
13
13
13
13
30
Sales/Revenue/Turnover
4
8
- -
1
3
1
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-85.63
-46.2
- -
2.18
-67.5
-105.24
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
2
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-4
3
- -
-2
-1
-1
-1
-1
-1
-38
35
-7
-9
Effective Tax Rate (%)
- -
- -
- -
18.75
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-85.63
-57.22
- -
1.77
-67.55
-105.38
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
-13
34
64
67
48
93
92
91
90
88
50
85
401
- -
LT Debt
- -
- -
- -
- -
4
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-2
34
64
67
95
93
92
91
90
88
50
85
401
- -
Return on Invested Capital (%)
- -
- -
6.81
0.02
- -
- -
- -
- -
- -
- -
- -
51.68
- -
- -
Return on Capital (%)
- -
- -
6.81
0.02
- -
- -
- -
- -
- -
- -
- -
51.69
- -
- -
Return on Common Equity (%)
- -
- -
7.06
0.02
-2.43
-0.58
-1.13
-1.27
-1.29
-1.54
-54.83
51.69
-2.94
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
16
45
44
Market Capitalization
1,356
4,479
5,495

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
453
- -
Cash, Cash Equivalents & STI
- -
374
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
52
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
43.57%
78.69%
369.59%
Free Cash Flow
-170,501.89%
-340,352.52%
-1,701,566.67%
Net Income, GAAP
-1,285.47%
473.86%
-120.39%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.07
2.81
-0.02
-0.02
2.7
2026
-0.09
-0.05
-0.02
-0.11
-0.55
2027
-0.06
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Ravindranath Rajaram
Full Time Employees
6
Sector
Producer manufacturing
Industry
Miscellaneous manufacturing
Address
VVN Residency Denduluru AP India
IPO Date
Nov 18, 2011
Website
genesisiil.com
Similar Companies
Astral Limited (NSE:ASTRAL)
Supreme Industries Limited (NSE:SUPREMEIND)
V.S. Industry Bhd. (MYX:VS)
Izmir Firca Sanayi ve Ticaret AS (BIST:IZFAS)
Kuzey Boru A.S. (BIST:KBORU)
Net Global Endustriyel Yatirimlar A.S. (BIST:NETGL)
Business
Genesis IBRC India Ltd is an integrated bio research and resource center primarily engaged in manufacturing and supplying sustainable solutions across aqua, poultry, veterinary, and agriculture sectors. The company offers a comprehensive product portfolio including microbial and antimicrobial products tailored for disease prevention, productivity enhancement, and cost reduction in aquaculture, poultry, and veterinary applications. Its core products include probiotics, aqua health supplements, soil probiotics, veterinary formulations, and agricultural bioinputs. The company also provides research and development services, consulting, and contract manufacturing for over 40 companies. Founded in 2011 and headquartered in Vijayawada, India, Genesis IBRC has expanded geographically with operations and distribution networks in Bangladesh, Thailand, Vietnam, UAE, Singapore, Brazil, and other global markets. Recent developments include strategic push towards global collaborations and strengthening its R&D capabilities, with continued emphasis on innovative ecofriendly microbial solutions and a focus on building international relationships. In 2025, Genesis IBRC underwent notable shareholding changes involving significant stake transactions and continues to report active engagement in board meetings and financial reporting, underscoring ongoing efforts to enhance corporate governance and operational transparency. The company remains committed to advancing organic and sustainable farming practices through its cellular input technologies and ecofriendly product innovations.